OraSure Technologies Inc (OSUR) stock
OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3037% below fair value
$3.51−0.09 (-2.50%)
Close on Nov 17, 2026Market cap $242.08MP/E –Yield –
OraSure Technologies r&d expenses
Research and development expenses are spending on new products and technology.
OraSure Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $44.62M, up 36.4% year over year. For fiscal 2025 it was $42.53M, up 63.3% from the year before. Over ten years it grew 13.8% a year on average. The highest annual figure on record is $42.53M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.53M | +63.3% |
| FY2024 | Dec 31, 2024 | $26.05M | -22.8% |
| FY2023 | Dec 31, 2023 | $33.73M | -6.9% |
| FY2022 | Dec 31, 2022 | $36.24M | +6.0% |
| FY2021 | Dec 31, 2021 | $34.17M | +10.1% |
| FY2020 | Dec 31, 2020 | $31.03M | +58.1% |
| FY2019 | Dec 31, 2019 | $19.63M | +20.8% |
| FY2018 | Dec 31, 2018 | $16.25M | +21.6% |
| FY2017 | Dec 31, 2017 | $13.37M | +37.0% |
| FY2016 | Dec 31, 2016 | $9.75M | -16.3% |
| FY2015 | Dec 31, 2015 | $11.65M | -3.4% |
| FY2014 | Dec 31, 2014 | $12.06M | +10.3% |
| FY2013 | Dec 31, 2013 | $10.93M | -12.2% |
| FY2012 | Dec 31, 2012 | $12.45M | -32.4% |
| FY2011 | Dec 31, 2011 | $18.41M | +39.5% |
| FY2010 | Dec 31, 2010 | $13.19M | -1.3% |
| FY2009 | Dec 31, 2009 | $13.37M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.44M | -17.2% |
| Q1 FY2026 | Mar 31, 2026 | $13.65M | +42.2% |
| Q4 FY2025 | Dec 31, 2025 | $11.42M | +87.6% |
| Q3 FY2025 | Sep 30, 2025 | $10.11M | +79.7% |
| Q2 FY2025 | Jun 30, 2025 | $11.40M | +72.8% |
| Q1 FY2025 | Mar 31, 2025 | $9.60M | +24.1% |
| Q4 FY2024 | Dec 31, 2024 | $6.09M | -12.9% |
| Q3 FY2024 | Sep 30, 2024 | $5.62M | -34.0% |
| Q2 FY2024 | Jun 30, 2024 | $6.60M | -13.9% |
| Q1 FY2024 | Mar 31, 2024 | $7.74M | -26.7% |
| Q4 FY2023 | Dec 31, 2023 | $6.99M | -13.2% |
| Q3 FY2023 | Sep 30, 2023 | $8.52M | -15.6% |
| Q2 FY2023 | Jun 30, 2023 | $7.66M | -19.0% |
| Q1 FY2023 | Mar 31, 2023 | $10.56M | +22.3% |
| Q4 FY2022 | Dec 31, 2022 | $8.05M | -9.5% |
| Q3 FY2022 | Sep 30, 2022 | $10.09M | +17.4% |
| Q2 FY2022 | Jun 30, 2022 | $9.46M | +23.2% |
| Q1 FY2022 | Mar 31, 2022 | $8.63M | -4.0% |
| Q4 FY2021 | Dec 31, 2021 | $8.90M | -14.9% |
| Q3 FY2021 | Sep 30, 2021 | $8.60M | +7.4% |
| Q2 FY2021 | Jun 30, 2021 | $7.68M | +10.9% |
| Q1 FY2021 | Mar 31, 2021 | $8.99M | +59.3% |
| Q4 FY2020 | Dec 31, 2020 | $10.46M | +71.3% |
| Q3 FY2020 | Sep 30, 2020 | $8.01M | +73.3% |
| Q2 FY2020 | Jun 30, 2020 | $6.92M | +52.7% |
| Q1 FY2020 | Mar 31, 2020 | $5.64M | +29.1% |
| Q4 FY2019 | Dec 31, 2019 | $6.10M | +50.4% |
| Q3 FY2019 | Sep 30, 2019 | $4.62M | +19.8% |
| Q2 FY2019 | Jun 30, 2019 | $4.54M | +6.4% |
| Q1 FY2019 | Mar 31, 2019 | $4.37M | +7.3% |
| Q4 FY2018 | Dec 31, 2018 | $4.06M | +6.0% |
| Q3 FY2018 | Sep 30, 2018 | $3.86M | +19.4% |
| Q2 FY2018 | Jun 30, 2018 | $4.26M | +27.7% |
| Q1 FY2018 | Mar 31, 2018 | $4.08M | +37.2% |
| Q4 FY2017 | Dec 31, 2017 | $3.83M | +217.2% |
| Q3 FY2017 | Sep 30, 2017 | $3.23M | +1.0% |
| Q2 FY2017 | Jun 30, 2017 | $3.34M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.97M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.21M | – |
| Q3 FY2016 | Sep 30, 2016 | $3.20M | – |
See a number that looks wrong?